Royal Bank of Canada »

Avadel Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 93k 12.72
2024-06-30 $1.4M 99k 14.06

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Avadel Pharmaceuticals

Henderson Group
Jeffrey L. Gendell
BlackRock
BlackRock
Vanguard Group
Braidwell
Citadel Advisors
Wealth Effects
Two Seas Capital
Vestal Point Capital
Woodline Partners
Brandes Investment Partners
Tang Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Avadel Pharmaceuticals